Search
Commonalities and Differences in Myeloid Malignancies: Insights from the EHA-SWG Scientific Meeting on MDS, MPN, and AML
November 2-4 - Budapest, Hungary
Meeting Chairs:
Konstanze Döhner, University Hospital Ulm, Germany
Claire Harrison, Guy's and St.
FDA Reports of Secondary Malignancies Following Chimeric Antigen Receptor (CAR) T Cell Therapies and Relative Risk: an EBMT-EHA-GoCART Coalition Statement
We need to bring your attention to the recent warning disseminated by the Food and Drug Administration (FDA) regarding T-cell lymphomas in patients undergoing Chimeric Antigen Receptor T-cell (CAR-T) therapy (1).
Read moreYoungEHA
Welcome to YoungEHA!As a junior member of EHA, you are part of the YoungEHA family.
Read moreI would like to be an EHA Member
Our members come from all corners of the world – from a University Hospitals in India to research companies in Germany.
Read moreJean Bernard Lifetime Achievement Award
The Jean Bernard Lifetime Achievement Award was established in 2008 to honor outstanding physicians and scientists for their lifetime contribution to the advancement of hematology.
Read moreEducation Committee
Current committee members
Konstanze Döhner, Germany (Chair)
Kirsten Grønbæk, Denmark (Vice-Chair)
Meritxell Alberich Jordà, Czech Republic (Councilor)
Antonio Almeida, Portugal (EHA President)
Nuno Borges, United Kingdom (YoungEHA representative)
Gianluca Gaidano, Italy (Chair Community and Stakeholder Committee)
Jose Tomás Navarro Ferrando, Spain (Chair Curriculum-Exam Committee)
Anna Porwit, Sweden (EHA…
EHA-ASH TRTH Joint Oversight Committee
Current committee members
John Crispino, USA (ASH Co-Director)
Shai Izraeli, Israel (EHA Co-Director)
Jose Lopez, USA (ASH Incoming Co-Director)
Jose Ignacio (Iñaki) Martin-Subrero, Spain (EHA Incoming Co-Director)
Alisa Wolberg, USA (ASH Executive Member)
Chiara Bonini, Italy (EHA Executive Member)
AimTo develop, in collaboration with ASH, translational researchers…
Research trainings
Old ways won't open new doors. Via non-pecuniary awards, EHA strives to accelerate the careers of promising post-docs in translational or clinical research.
Read moreEHA-ECL led statement calls for protection of the Hospital Exemption
The hospital exemption (HE) is a vital provision within the EU's pharmaceutical legislation, currently subject to a revision.
Read more